Darktrace has announced strong demand for its latest product release, Version 5 of its self-learning Darktrace Immune System, as customers tackle security challenges related to home working, and the new wave of sophisticated cyber-attacks.
Requests to trial its award-winning Cyber AI technology in December 2020, when the security industry was rattled by the compromise of SolarWinds which made thousands of organisations vulnerable to infiltration, were up 40% compared to December 2019. Darktrace's global customer base now numbers over 4,500 organisations, including Micron, Rolls-Royce and NHS trusts, and its headcount has recently risen to 1,500 employees.
In the APAC region, Darktrace increased its customer base by almost 30% with significant growth in the Singapore region and counts blue-chip organisations such as International Baccalaureate, AWWA, and several healthcare and pharmaceutical organisations space such as Santen Pharmaceutical and Farrer Park Group on its client roster.
"Recent attacks, including the malicious campaign related to SolarWinds, have laid bare the inadequacy of signature-based tools in protecting against stealthy intruders that lie low inside digital systems," said Poppy Gustafsson, CEO of Darktrace. "Darktrace's AI is designed to detect these types of novel threats and intervene immediately to stop their spread. The demand for our latest release is testimony to Darktrace's unique position in helping CISOs upgrade their security, as they seek to protect their entire digital infrastructure in the cloud, email, home office or network environments."
"At Darktrace, we have a track record of innovation and providing our customers with the technology they need to keep up with the most complex attacks," said Nicole Eagan, Chief Strategy Officer. "We have seen an increased need for autonomous cyber defences companies have transitioned to work from home and adopted more cloud-based tools."
Hundreds of customers have already provided feedback on Darktrace Version 5, which encompasses upgrades to a range of Darktrace products including Antigena Email, Antigena SaaS, Client Sensors, Enterprise Immune System and Industrial Immune System. This is the first time Darktrace simultaneously upgraded its broad product portfolio, emphasising its commitment to covering its customers' entire digital estate.
"Darktrace's technology is second to none in its ability to deal the new era of attacks which are increasingly silent yet extremely sophisticated," said James Chua, General Manager at Global Travel. "Cyber security is no longer a problem that humans can deal with alone and next generation technology, like Darktrace AI, have the intelligence to act swiftly on behalf of humans. The capability to autonomously and intelligently react at machine-speed is absolutely critical for us."